Early Benefit of Implantable Cardioverter Defibrillator Therapy in Patients Waiting for Cardiac Transplantation

The ICD can effectively recognize and treat ventricular arrhythmias that can lead to sudden death. Sudden death is a major problem in patients awaiting heart transplantation. We reviewed our experience with the ICD in patients with malignant ventricular arrhythmias waiting for cardiac transplantatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pacing and clinical electrophysiology 1998-09, Vol.21 (9), p.1747-1750
Hauptverfasser: LORGA-FILHO, ADALBERTO, GEELEN, PETER, VANDERHEYDEN, MARC, MALACKY, TIBOR, PRIMO, JOAO, GOETHALS, MARC, WELLENS, FRANCIS, BRUGADA, PEDRO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1750
container_issue 9
container_start_page 1747
container_title Pacing and clinical electrophysiology
container_volume 21
creator LORGA-FILHO, ADALBERTO
GEELEN, PETER
VANDERHEYDEN, MARC
MALACKY, TIBOR
PRIMO, JOAO
GOETHALS, MARC
WELLENS, FRANCIS
BRUGADA, PEDRO
description The ICD can effectively recognize and treat ventricular arrhythmias that can lead to sudden death. Sudden death is a major problem in patients awaiting heart transplantation. We reviewed our experience with the ICD in patients with malignant ventricular arrhythmias waiting for cardiac transplantation. Nineteen patients were included. Seventeen were men, mean age was 54 ±11 years (range 17–66) and the left ventricular ejection fraction was 22%± 10% (range 9%–46%). After a mean follow–up of 6 ± 5 months (range 1–20 months), 17 patients reached heart transplantation. One patient died and the other is waiting for a transplant. Before transplantation 71 % of patients received an appropriate discharge. The mean time to the first appropriate discharge was 2 ± 2 months (range < 1–6 months), which was significantly shorter than the mean time to first discharge in the other patients (n = 182) receiving a defibrillator in our center (11 ±10 months; range 1–58 months) (P < 0.0004). In conclusion, cardiac transplantation candidates with life–threatening ventricular arrhythmias can effectively be protected against sudden arrhythmic death by ICD. These patients have a high incidence of appropriate shocks occurring very early after implantation.
doi_str_mv 10.1111/j.1540-8159.1998.tb00274.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73931582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73931582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4097-80644bddae283522db39ead8e0836d0cf92a772d6307ed62af1506989c9d74b03</originalsourceid><addsrcrecordid>eNqVkMGO0zAQhi0EWsrCIyBZHLgljGMntjmx25ZlxQJ7KOzRcuIJuKRJsV1o356UVL3jyxz-fz6PPkJeMcjZ-N6sc1YKyBQrdc60VnmqAQop8v0jMjtHj8kMmJCZ4ko_Jc9iXANABaK8IBdaCiG4mpFhaUN3oNfYY-sTHVp6u9l2tk-27pDObXB--I0hYaCLsVEH33U2DYGufmCw2wP1Pb23yWOfIn2wPvn-O23H_N-qbegq2D5OxOSH_jl50tou4ovTvCRf3y9X8w_Z3Zeb2_nVXdYI0OPNUAlRO2exULwsCldzjdYpBMUrB02rCytl4SoOEl1V2JaVUGmlG-2kqIFfktcTdxuGXzuMyWx8bHA8vsdhF43kmrNSFWPx7VRswhBjwNZsg9_YcDAMzNG2WZujUnNUao62zcm22Y_LL0-_7OoNuvPqSe-Yv5vyP77Dw3-Qzf3VfMmkkCMimxA-JtyfETb8NJXksjQPn2_MpxX_-E3Cwiz4X_a_oIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73931582</pqid></control><display><type>article</type><title>Early Benefit of Implantable Cardioverter Defibrillator Therapy in Patients Waiting for Cardiac Transplantation</title><source>MEDLINE</source><source>Wiley Journals</source><creator>LORGA-FILHO, ADALBERTO ; GEELEN, PETER ; VANDERHEYDEN, MARC ; MALACKY, TIBOR ; PRIMO, JOAO ; GOETHALS, MARC ; WELLENS, FRANCIS ; BRUGADA, PEDRO</creator><creatorcontrib>LORGA-FILHO, ADALBERTO ; GEELEN, PETER ; VANDERHEYDEN, MARC ; MALACKY, TIBOR ; PRIMO, JOAO ; GOETHALS, MARC ; WELLENS, FRANCIS ; BRUGADA, PEDRO</creatorcontrib><description>The ICD can effectively recognize and treat ventricular arrhythmias that can lead to sudden death. Sudden death is a major problem in patients awaiting heart transplantation. We reviewed our experience with the ICD in patients with malignant ventricular arrhythmias waiting for cardiac transplantation. Nineteen patients were included. Seventeen were men, mean age was 54 ±11 years (range 17–66) and the left ventricular ejection fraction was 22%± 10% (range 9%–46%). After a mean follow–up of 6 ± 5 months (range 1–20 months), 17 patients reached heart transplantation. One patient died and the other is waiting for a transplant. Before transplantation 71 % of patients received an appropriate discharge. The mean time to the first appropriate discharge was 2 ± 2 months (range &lt; 1–6 months), which was significantly shorter than the mean time to first discharge in the other patients (n = 182) receiving a defibrillator in our center (11 ±10 months; range 1–58 months) (P &lt; 0.0004). In conclusion, cardiac transplantation candidates with life–threatening ventricular arrhythmias can effectively be protected against sudden arrhythmic death by ICD. These patients have a high incidence of appropriate shocks occurring very early after implantation.</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/j.1540-8159.1998.tb00274.x</identifier><identifier>PMID: 9744438</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; cardiac transplantation ; Death, Sudden, Cardiac - prevention &amp; control ; Defibrillators, Implantable ; Female ; Heart Transplantation - physiology ; Humans ; implantable Cardioverter defibrillator ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Stroke Volume - physiology ; sudden death ; Tachycardia, Ventricular - physiopathology ; Tachycardia, Ventricular - prevention &amp; control ; Treatment Outcome ; ventricular arrhythmia ; Ventricular Fibrillation - physiopathology ; Ventricular Fibrillation - prevention &amp; control ; Ventricular Function, Left - physiology ; Waiting Lists</subject><ispartof>Pacing and clinical electrophysiology, 1998-09, Vol.21 (9), p.1747-1750</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4097-80644bddae283522db39ead8e0836d0cf92a772d6307ed62af1506989c9d74b03</citedby><cites>FETCH-LOGICAL-c4097-80644bddae283522db39ead8e0836d0cf92a772d6307ed62af1506989c9d74b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1540-8159.1998.tb00274.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1540-8159.1998.tb00274.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9744438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LORGA-FILHO, ADALBERTO</creatorcontrib><creatorcontrib>GEELEN, PETER</creatorcontrib><creatorcontrib>VANDERHEYDEN, MARC</creatorcontrib><creatorcontrib>MALACKY, TIBOR</creatorcontrib><creatorcontrib>PRIMO, JOAO</creatorcontrib><creatorcontrib>GOETHALS, MARC</creatorcontrib><creatorcontrib>WELLENS, FRANCIS</creatorcontrib><creatorcontrib>BRUGADA, PEDRO</creatorcontrib><title>Early Benefit of Implantable Cardioverter Defibrillator Therapy in Patients Waiting for Cardiac Transplantation</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>The ICD can effectively recognize and treat ventricular arrhythmias that can lead to sudden death. Sudden death is a major problem in patients awaiting heart transplantation. We reviewed our experience with the ICD in patients with malignant ventricular arrhythmias waiting for cardiac transplantation. Nineteen patients were included. Seventeen were men, mean age was 54 ±11 years (range 17–66) and the left ventricular ejection fraction was 22%± 10% (range 9%–46%). After a mean follow–up of 6 ± 5 months (range 1–20 months), 17 patients reached heart transplantation. One patient died and the other is waiting for a transplant. Before transplantation 71 % of patients received an appropriate discharge. The mean time to the first appropriate discharge was 2 ± 2 months (range &lt; 1–6 months), which was significantly shorter than the mean time to first discharge in the other patients (n = 182) receiving a defibrillator in our center (11 ±10 months; range 1–58 months) (P &lt; 0.0004). In conclusion, cardiac transplantation candidates with life–threatening ventricular arrhythmias can effectively be protected against sudden arrhythmic death by ICD. These patients have a high incidence of appropriate shocks occurring very early after implantation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>cardiac transplantation</subject><subject>Death, Sudden, Cardiac - prevention &amp; control</subject><subject>Defibrillators, Implantable</subject><subject>Female</subject><subject>Heart Transplantation - physiology</subject><subject>Humans</subject><subject>implantable Cardioverter defibrillator</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Stroke Volume - physiology</subject><subject>sudden death</subject><subject>Tachycardia, Ventricular - physiopathology</subject><subject>Tachycardia, Ventricular - prevention &amp; control</subject><subject>Treatment Outcome</subject><subject>ventricular arrhythmia</subject><subject>Ventricular Fibrillation - physiopathology</subject><subject>Ventricular Fibrillation - prevention &amp; control</subject><subject>Ventricular Function, Left - physiology</subject><subject>Waiting Lists</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkMGO0zAQhi0EWsrCIyBZHLgljGMntjmx25ZlxQJ7KOzRcuIJuKRJsV1o356UVL3jyxz-fz6PPkJeMcjZ-N6sc1YKyBQrdc60VnmqAQop8v0jMjtHj8kMmJCZ4ko_Jc9iXANABaK8IBdaCiG4mpFhaUN3oNfYY-sTHVp6u9l2tk-27pDObXB--I0hYaCLsVEH33U2DYGufmCw2wP1Pb23yWOfIn2wPvn-O23H_N-qbegq2D5OxOSH_jl50tou4ovTvCRf3y9X8w_Z3Zeb2_nVXdYI0OPNUAlRO2exULwsCldzjdYpBMUrB02rCytl4SoOEl1V2JaVUGmlG-2kqIFfktcTdxuGXzuMyWx8bHA8vsdhF43kmrNSFWPx7VRswhBjwNZsg9_YcDAMzNG2WZujUnNUao62zcm22Y_LL0-_7OoNuvPqSe-Yv5vyP77Dw3-Qzf3VfMmkkCMimxA-JtyfETb8NJXksjQPn2_MpxX_-E3Cwiz4X_a_oIw</recordid><startdate>199809</startdate><enddate>199809</enddate><creator>LORGA-FILHO, ADALBERTO</creator><creator>GEELEN, PETER</creator><creator>VANDERHEYDEN, MARC</creator><creator>MALACKY, TIBOR</creator><creator>PRIMO, JOAO</creator><creator>GOETHALS, MARC</creator><creator>WELLENS, FRANCIS</creator><creator>BRUGADA, PEDRO</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199809</creationdate><title>Early Benefit of Implantable Cardioverter Defibrillator Therapy in Patients Waiting for Cardiac Transplantation</title><author>LORGA-FILHO, ADALBERTO ; GEELEN, PETER ; VANDERHEYDEN, MARC ; MALACKY, TIBOR ; PRIMO, JOAO ; GOETHALS, MARC ; WELLENS, FRANCIS ; BRUGADA, PEDRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4097-80644bddae283522db39ead8e0836d0cf92a772d6307ed62af1506989c9d74b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>cardiac transplantation</topic><topic>Death, Sudden, Cardiac - prevention &amp; control</topic><topic>Defibrillators, Implantable</topic><topic>Female</topic><topic>Heart Transplantation - physiology</topic><topic>Humans</topic><topic>implantable Cardioverter defibrillator</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Stroke Volume - physiology</topic><topic>sudden death</topic><topic>Tachycardia, Ventricular - physiopathology</topic><topic>Tachycardia, Ventricular - prevention &amp; control</topic><topic>Treatment Outcome</topic><topic>ventricular arrhythmia</topic><topic>Ventricular Fibrillation - physiopathology</topic><topic>Ventricular Fibrillation - prevention &amp; control</topic><topic>Ventricular Function, Left - physiology</topic><topic>Waiting Lists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LORGA-FILHO, ADALBERTO</creatorcontrib><creatorcontrib>GEELEN, PETER</creatorcontrib><creatorcontrib>VANDERHEYDEN, MARC</creatorcontrib><creatorcontrib>MALACKY, TIBOR</creatorcontrib><creatorcontrib>PRIMO, JOAO</creatorcontrib><creatorcontrib>GOETHALS, MARC</creatorcontrib><creatorcontrib>WELLENS, FRANCIS</creatorcontrib><creatorcontrib>BRUGADA, PEDRO</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LORGA-FILHO, ADALBERTO</au><au>GEELEN, PETER</au><au>VANDERHEYDEN, MARC</au><au>MALACKY, TIBOR</au><au>PRIMO, JOAO</au><au>GOETHALS, MARC</au><au>WELLENS, FRANCIS</au><au>BRUGADA, PEDRO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early Benefit of Implantable Cardioverter Defibrillator Therapy in Patients Waiting for Cardiac Transplantation</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>1998-09</date><risdate>1998</risdate><volume>21</volume><issue>9</issue><spage>1747</spage><epage>1750</epage><pages>1747-1750</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>The ICD can effectively recognize and treat ventricular arrhythmias that can lead to sudden death. Sudden death is a major problem in patients awaiting heart transplantation. We reviewed our experience with the ICD in patients with malignant ventricular arrhythmias waiting for cardiac transplantation. Nineteen patients were included. Seventeen were men, mean age was 54 ±11 years (range 17–66) and the left ventricular ejection fraction was 22%± 10% (range 9%–46%). After a mean follow–up of 6 ± 5 months (range 1–20 months), 17 patients reached heart transplantation. One patient died and the other is waiting for a transplant. Before transplantation 71 % of patients received an appropriate discharge. The mean time to the first appropriate discharge was 2 ± 2 months (range &lt; 1–6 months), which was significantly shorter than the mean time to first discharge in the other patients (n = 182) receiving a defibrillator in our center (11 ±10 months; range 1–58 months) (P &lt; 0.0004). In conclusion, cardiac transplantation candidates with life–threatening ventricular arrhythmias can effectively be protected against sudden arrhythmic death by ICD. These patients have a high incidence of appropriate shocks occurring very early after implantation.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>9744438</pmid><doi>10.1111/j.1540-8159.1998.tb00274.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0147-8389
ispartof Pacing and clinical electrophysiology, 1998-09, Vol.21 (9), p.1747-1750
issn 0147-8389
1540-8159
language eng
recordid cdi_proquest_miscellaneous_73931582
source MEDLINE; Wiley Journals
subjects Adolescent
Adult
Aged
cardiac transplantation
Death, Sudden, Cardiac - prevention & control
Defibrillators, Implantable
Female
Heart Transplantation - physiology
Humans
implantable Cardioverter defibrillator
Male
Middle Aged
Retrospective Studies
Risk Factors
Stroke Volume - physiology
sudden death
Tachycardia, Ventricular - physiopathology
Tachycardia, Ventricular - prevention & control
Treatment Outcome
ventricular arrhythmia
Ventricular Fibrillation - physiopathology
Ventricular Fibrillation - prevention & control
Ventricular Function, Left - physiology
Waiting Lists
title Early Benefit of Implantable Cardioverter Defibrillator Therapy in Patients Waiting for Cardiac Transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A57%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20Benefit%20of%20Implantable%20Cardioverter%20Defibrillator%20Therapy%20in%20Patients%20Waiting%20for%20Cardiac%20Transplantation&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=LORGA-FILHO,%20ADALBERTO&rft.date=1998-09&rft.volume=21&rft.issue=9&rft.spage=1747&rft.epage=1750&rft.pages=1747-1750&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/j.1540-8159.1998.tb00274.x&rft_dat=%3Cproquest_cross%3E73931582%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73931582&rft_id=info:pmid/9744438&rfr_iscdi=true